The GentleWave® System by Sonendo® nominated for 2021 Prix Galien USA Best Medical Technology Award

Sonendo®, Inc., a leading dental technology company, has announced that its GentleWave® System has been nominated as a 2021 Prix Galien USA Award finalist for this year’s Best Medical Technology Award.

This year’s ceremony is Prix Galien’s 50th, marking half a century of recognising excellence in biopharmaceutical and medical technology innovations that improve the human condition. Winners will be announced during the Prix Galien USA Awards Ceremony on 28 October 2021 in New York City, United States.

The GentleWave System by Sonendo ushers in the next evolution in endodontic technology that is transforming a rapidly growing number of practices across North America. The GentleWave System uses patented, novel technology designed to deliver more thorough cleaning and disinfection to the entire root canal system – even in microscopic places where bacteria can hide- and leave more of the tooth structure intact1,2.

Most GentleWave Procedures can be performed in one visit and patients have found the procedure to be comfortable and have reported minimal to no post procedure pain3. Additionally, the system is designed to generate virtually no aerosolised material into the air during normal use4, which has become an important issue for clinicians and patients during the COVID-19 pandemic due to the heightened sensitivity to the concerns associated with cross-contamination via aerosol. Procedure Instruments for the GentleWave System also come pre-sterilised and are single use, hence minimising the risk of exposure from one patient to the next.

“It’s a tremendous honour to be nominated for this prestigious award,” said Michael Smith, chief commercial officer of Sonendo. “Being recognised as a ground-breaking and impactful technology by some of the greatest science and medical thought leaders further underscores our belief that our system is fast becoming the new standard for cleanliness and clinical ease of use in root canal therapy. We are grateful to the Prix Gailen Awards selection committee for the recognition.”

“The Awards Committee is excited to introduce this year’s nominees for the Prix Galien USA Awards. These products have been created by scientists who have dedicated their lives to discovering, developing and distributing life-saving answers for patients,” said Dr Sue Desmond-Hellmann, chair of the Prix Galien USA and Prix Galien International Award Committees and former chief executive officer of the Bill & Melinda Gates Foundation. “We appreciate the opportunity to honour these researchers and their tireless efforts.”

The Prix Galien USA Awards Committee is composed of twelve renowned leaders from the biomedical industry and academia, including five Nobel Laureates, responsible for evaluating nominees.


1Sigurdsson A et al. (2016) J Endod. 42:1040-48.

2Molina B et al. (2015) J Endod. 41:1701-05.

3Sigurdsson et al. J Endod 2018; 44(3):510-517.

4Data on file at Sonendo; TR20-0027.